Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain

Neuroscience Letters

Volumn 225, Issue 2, 1997, Pages 73-76

  Liang, Jun shan ^a   Sloane, Jacob A ^a   Wells, John M ^a,b   Abraham, Carmela R ^a   Fine, Richard E ^a,b   Sipe, Jean D ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Brain; Inflammation; Serum amyloid A

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID BETA PROTEIN; APOLIPOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS; BLOTTING, WESTERN; BRAIN; FEMALE; HUMANS; MALE; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 0031552382     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00196-1     Document Type: Article

References (13)

1. Blusztajn J.K., Gonzalez-Coviella I.L., Logue M., Growdon J.H., Wurtman R.J. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients. Brain Res. 536:1990;240-244.
2. Hardardottir, I., Sipe, J.D., Moser, A.H., Fielding, C.J., Feingold, K.R. and Grunfeld, C., LPS and cytokines regulate extrahepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters, Biochim. Biophys. Acta, (1997) in press.
3. Husby G., Marhaug G., Dowton B., Sletten K., Sipe J.D. Serum amyloid A (SAA): biochemistry, genetics and pathogenesis of AA amyloidosis. Amyloid Int. J. Exp. Clin. Invest. 1:1994;119-137.
4. Kanemaru K., Meckelein B., Marshall D.L., Sipe J.D., Abraham C.R. Synthesis and secretion of active α1-antichymotrypsin by murine primary astrocytes. Neurobiol. Aging. 17:1996;767-771.
5. Liang J.S., Schreiber B.M., Salmona M., Phillip G., Gonnerman W.A., de Beer F.C., Sipe J.D. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and Hep G2 cells. J. Lipid Res. 37:1996;2109-2116.
6. Liang J.-S., Fine R.E., Abraham C.R., Sipe J.D. The fibril forming region of the β-amyloid precursor differs from that of the amyloid A precursor in its interaction with lipids. Biochem. Biophys. Res. Commun. 219:1996;962-967.
7. Mackiewicz, A., Kushner, I. and Baumann, H., Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Applications, CRC Press, Boca Raton, FL, 1993.
8. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
9. Nitsch R.M., Blusztajn J.K., Pittas A.J., Slack B.E., Growdon J.H., Wurtman R.J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. Natl. Acad. Sci. USA. 89:1992;1671-1675.
10. Pruzanski W., de Beer F.C., de Beer M.C., Stefanski E., Vadas P. Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2. Biochem. J. 309:1995;461-464.
11. Rogers J. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneim.-Forsch./Drug Res. 45:1995;439-442.
12. Sipe J.D., Colten H.R., Goldberger D., Edge M.D., Tack B.F., Cohen A.S., Whitehead A.S. Human serum amyloid A (SAA): biosynthesis and postsynthetic processing of preSAA and structural variants defined by complementary DNA. Biochemistry. 24:1985;2931-2936.
13. Whitehead A.S., de Beer M.C., Steel D.M., Rits M., Lelias J.M., Lane W.S., de Beer F.C. Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 267:1992;3862-3867.